|
|
|
Wednesday, January 7, 2009
|
Horizon Therapeutics Announces Senior Management Appointments
HSMN NewsFeed,
6 Jan 2009:
Biopharmaceuticals, Personnel
[Horizon Therapeutics]
|
BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
HSMN NewsFeed,
6 Jan 2009:
Biopharmaceuticals
[La Jolla Pharmaceutical, BioMarin Pharmaceutical, Riquent, lupus nephritis]
|
TomoTherapy Tops MD Buyline Review of Radiation Therapy Vendors
HSMN NewsFeed,
6 Jan 2009:
Devices, Oncology
[TomoTherapy, Hi·Art, radiotherapy]
|
Two-Year Study Confirms Use of LeMaitre Vascular's Endovascular Stent Graft to Treat Thoracic Aortic Disease
HSMN NewsFeed,
6 Jan 2009:
Devices, Cardiology, Surgery
[LeMaitre Vascular, stent graft, aortic aneurysm]
|
Kawasaki Disease Treated with Plasma-Derived Therapy
HSMN NewsFeed,
6 Jan 2009:
Biopharmaceuticals
[Kawasaki disease, immune globulin]
|
MEDRAD Sponsors PET Research with University of Zurich
HSMN NewsFeed,
6 Jan 2009:
Devices, Drug Delivery, Radiology, Oncology
[MEDRAD, fluorodeoxyglucose, FDG, PET Scan]
|
Court Rules in Favor of Medtronic in Fidelis Litigation
HSMN NewsFeed,
6 Jan 2009:
Devices, Cardiology, Litigation
[Medtronic, Sprint Fidelis, defibrillator lead]
|
Boston Scientific Acquires Labcoat Limited
HSMN NewsFeed,
6 Jan 2009:
Devices, Interventional Cardiology, Mergers & Acquisitions
[Boston Scientific, Labcoat Limited, JACTAX, paclitaxel, drug eluting stent]
|
Vicor Technologies Announces Receipt of 510(k) Approval to Market Its PD2i Analyzer
HSMN NewsFeed,
6 Jan 2009:
Devices, Monitoring, Cardiology, FDA
[Vicor Technologies, PD2i Analyzer]
|
German Appeals Court Rules in Favor of AGA Medical in Patent Infringement Lawsuit Against Occlutech
HSMN NewsFeed,
6 Jan 2009:
Devices, Interventional, Litigation
[AGA Medical Holdings, Occlutech, Amplatz]
|
Anacor Raises $50 Million in Equity Financing
HSMN NewsFeed,
6 Jan 2009:
Biopharmaceuticals, Venture Capital
[Anacor Pharmaceuticals, GlaxoSmithKline, Schering]
|
Valeant Pharmaceuticals Appoints Chief Operating Officer of Specialty Pharmaceuticals
HSMN NewsFeed,
6 Jan 2009:
Biopharmaceuticals, Dermatology, Personnel
[Valeant Pharmaceuticals]
|
New Milestones for Ikonisys’ oncoFISH(R) cervical Test
HSMN NewsFeed,
6 Jan 2009:
Diagnostics, Oncology
[Ikonisys, oncoFISH, cervical cancer, fluorescence in situ hybridization]
|
ARIAD Expands Management Team with Executive Appointments in Regulatory Affairs, Manufacturing and Information Technology
HSMN NewsFeed,
6 Jan 2009:
Biopharmaceuticals, Personnel
[ARIAD Pharmaceuticals]
|
DOR BioPharma Obtains Fast Track Designation for DOR201 in the Prevention of Acute Radiation Enteritis
HSMN NewsFeed,
6 Jan 2009:
Biopharmaceuticals
[DOR BioPharma, DOR201, beclomethasone dipropionate, fast track designation]
|
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
HSMN NewsFeed,
6 Jan 2009:
Biopharmaceuticals, Regulatory
[MedImmune, AstraZeneca, influenza, LAIV]
|
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
HSMN NewsFeed,
5 Jan 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Indevus Pharmaceuticals, Endo Pharmaceuticals, NEBIDO]
|
Misonix Announces New HIFU Distribution Agreement for Italy
HSMN NewsFeed,
5 Jan 2009:
Devices, Distribution
[Misonix, Alliance Lithomobile, Sonablate 500, HIFU]
|
Medtronic Announces Clinical Trial of Stent for Peripheral Arterial Disease
HSMN NewsFeed,
5 Jan 2009:
Devices, Interventional
[Medtronic, Complete SE stent, Peripheral Arterial Disease, SFA study]
|
Impax Appoints Christopher Mengler, R. PH., President of Global Pharmaceuticals Division
HSMN NewsFeed,
5 Jan 2009:
Biopharmaceuticals, Personnel
[IMPAX Laboratories]
|
Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
HSMN NewsFeed,
5 Jan 2009:
Biopharmaceuticals, Cardiology
[Prism Pharmaceuticals, NEXTERONE, amiodarone, Wyeth, Cordarone]
|
Medtronic Launches Its First Integrated Power Console (IPC) Platform for Use in Spinal, Cranial, and Ear, Nose, and Throat Surgeries
HSMN NewsFeed,
5 Jan 2009:
Devices
[Medtronic, Midas Rex, IPC platform]
|
Depomed Announces Management Promotions
HSMN NewsFeed,
5 Jan 2009:
Biopharmaceuticals, Personnel
[Depomed]
|
Meda Acquires World-Wide Rights to Onsolis
HSMN NewsFeed,
5 Jan 2009:
Biopharmaceuticals, Distribution
[Meda AB, BioDelivery Sciences International, ONSOLIS, BEMA Fentanyl]
|
BioDelivery Sciences Closes $6 Million Transaction with Meda
HSMN NewsFeed,
5 Jan 2009:
Biopharmaceuticals, Distribution
[BioDelivery Sciences International, Meda AB, ONSOLIS, BEMA Fentanyl]
|
FDA Announces Class I Recall of Ophthalmic Surgical Device
HSMN NewsFeed,
2 Jan 2009:
Devices, Ophthalmology, Surgery, FDA, Product Recall
[Advanced Medical Optics, Healon D, ophthalmic viscosurgical device]
|
Valeant Pharmaceuticals Completes Acquisition of Dow Pharmaceutical Sciences, Inc.
HSMN NewsFeed,
2 Jan 2009:
Biopharmaceuticals, Acquisitions, Dermatology
[Valeant Pharmaceuticals, Dow Pharmaceutical Sciences]
|
New Drug Application Submitted For Acurox(r) Tablets
HSMN NewsFeed,
2 Jan 2009:
Biopharmaceuticals
[Acura Pharmaceuticals, King Pharmaceuticals, Acurox, oxycodone]
|
First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
HSMN NewsFeed,
31 Dec 2008:
Devices, Interventional, Oncology
[CeloNova BioSciences, Embozene, microspheres, embolization]
|
Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
HSMN NewsFeed,
31 Dec 2008:
Biopharmaceuticals, Drug Delivery, Acquisitions
[Nektar Therapeutics, Novartis, Tobramycin]
|
PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
HSMN NewsFeed,
31 Dec 2008:
Biopharmaceuticals, Drug Delivery, Product Recall
[PriCara, Ortho-McNeil-Janssen Pharmaceuticals, DURAGESIC, fentanyl transdermal]
|
FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel
HSMN NewsFeed,
31 Dec 2008:
Biopharmaceuticals, Cardiology
[Eli Lilly, Daiichi Sankyo, Prasugrel, acute coronary syndrome]
|
Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain
HSMN NewsFeed,
31 Dec 2008:
Biopharmaceuticals, FDA
[Labopharm, tramadol, RYZOLT]
|
FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
HSMN NewsFeed,
31 Dec 2008:
Diagnostics, FDA
[Roche Group, TaqScreen MPX]
|
China Medical Technologies Announces the Completion of the Sale of its HIFU Business
HSMN NewsFeed,
31 Dec 2008:
Devices, Acquisitions
[China Medical Technologies, Chengxuan, HIFU]
|
|
|
|
|
Public
Feeds 
Full text >>